Últimas noticias sobre Momentus (NASDAQ:MNTS) Bolsa

Momentus

Momentus Inc offers in-space infrastructure services by building transfer and service vehicles that carry satellites and hosted payloads between orbits in space. It is a provider of three critical functions, in the new space economy: Space Transportation, Satellite as a Service, and In-Orbit Servicing.

Momentus Inc

WIIM

OMCL

Omnicell shares are trading higher after the company reported better-than-expected Q2 financial results, issued Q3 sales guidance above estimates, and raised its FY25 guidance.

Oppenheimer analyst Michael Wiederhorn maintains Chemed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHE#NYSE">CHE</a>) with a Outperform and lowers the price target from $650 to $580.

News

Price Target

Analyst Ratings

Oppenheimer Maintains Outperform on Chemed, Lowers Price Target to $580

MDXG

MiMedx Group shares are trading higher after the company reported better-than-expected Q2 financial results.

Rush Street Interactive shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY25 sales guidance. Also, Needham raised its price target on the stock from  $17 to $21.

SNDL

SNDL shares are trading higher after the company reported better-than-expected Q2 financial results.

PALI-2108 is the first and only PDE4 inhibitor designed to target terminal ileum and colon for fibrostenotic Crohn's disease (FSCD) and ulcerative colitis (UC), to address significant unmet medical needs Inflammatory Bowel Disease is a large and growing market opportunity in China, with forecasts approaching $1B in total revenues by 2030
Carlsbad, CA, July 31, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PALI#NASDAQ">PALI</a>) ("Palisade," "Palisade Bio," or the "Company"), a clinical-stage biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced that the China National Intellectual Property Administration has issued a Notice of Allowance for a patent covering PALI-2108, the Company's novel, locally-activated, terminal ileum and colon-targeted phosphodiesterase-4 B/D (PDE4 B/D) inhibitor being developed for fibrostenotic Crohn's disease (FSCD) and moderate to severe ulcerative colitis (UC).
Once issued, the allowed patent titled, "Gut Microbiota-Activated PDE4 Inhibitor Prodrug," will cover claims on the composition of matter for PALI-2108 in China with a base patent term currently extending into 2045, subject to extension to account for time required to fulfill requirements for regulatory approval.

Biotech

Global

General

PALI

Palisade Bio Secures China Patent For PALI-2108, A Targeted PDE4 Inhibitor For Crohn's Disease And Ulcerative Colitis

CVR Energy shares are trading lower following a Q2 adjusted EPS miss.

VCEL

Vericel shares are trading lower after the company reported a Q2 revenue miss.

WeRide shares are trading higher following the release of its Q2 financial results.

APLS

Apellis Pharmaceuticals shares are trading higher after the company reported a Q2 EPS beat.

CMCSA

During Conf Call, Comcast Says About Half Of Eligible New Customers Choosing 5-Year Price Guarantee In Q2

TENB

TransMedics Group shares are trading higher after the company reported better-than-expected Q2 EPS results and raised its FY25 sales guidance above estimates. Also, Needham raised its price target on the stock from $35 to $42.

INDV

Indivior shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY25 sales guidance above estimates.

First sublingual pre-workout single-serving supplement that delivers 50mg of caffeine rapidly to the body, is now available to order via Aspire's new direct-to-consumer shopping experience
ESTERO, FL / <a href="https://www.accessnewswire.com/">ACCESS Newswire</a> / July 31, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASBP#NASDAQ">ASBP</a>) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending supplement delivery technology, today announced the rollout of its new e-commerce solution, <a href="https://pr.report/cuce">buzzbomb.buzz</a> with BUZZ BOMB&#x2122; as its featured launch product. This new seamless direct-to-consumer shopping experience allows consumers to order BUZZ BOMB&#x2122; on the Aspire platform and have them shipped directly to their door with access to exclusive promotions, and customer support. To celebrate the launch, customers who register for Aspire's e-commerce site will have first access to special pricing, free shipping offers, and other promotions. The site features an introductory sample pack of four flavors as well as 30-packs in various configurations.

ASBP

Aspire Biopharma Launches Direct-To-Consumer Site Featuring BUZZ BOMB, First Rapid-Delivery Sublingual Pre-Workout Supplement

SHAK

Shake Shack shares are trading lower following the release of its Q2 financial results.

Short Sellers

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

Currenc Group Retains Shareholder Intelligence Services To Assist In Monitoring And Investigating Potential Naked Short Selling

Commercial-Scale AirSCWO System Consistently Destroys PFAS in Biosolids to Non-Detectable Levels
Disposal of PFAS Contaminated Biosolids from Wastewater Treatment Plants is Growing Nationwide Issue
DURHAM, N.C., July 31, 2025 (GLOBE NEWSWIRE) -- 374Water Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCWO#NASDAQ">SCWO</a>) ("374Water") (the "Company"), a global leader in organic waste destruction technology and services for the municipal, federal, and industrial markets, today announced the successful waste destruction of PFAS in biosolids utilizing our commercial-scale AirSCWO system. These waste destruction results showcase the effectiveness of our AirSCWO technology to destroy one of the hardest, most problematic waste streams containing toxic "forever chemicals", producing effluent with PFAS concentrations at non-detectable levels.
Biosolids are the organic materials that remain after effluent has been treated at a wastewater treatment plant. Biosolids are a necessary byproduct of wastewater treatment, but growing concerns over toxins, environmental impact, and limited disposal options have turned biosolid management into a pressing national issue.
Especially concerning are per- and polyfluoroalkyl ("PFAS") contaminated wastes. PFAS "forever chemicals" are a group of thousands of synthetic chemicals which are persistent and hazardous. Toxic PFAS are found in many everyday products that are included in the wastewater stream from homes and businesses. When biosolids are disposed of via land application, PFAS can contaminate soil, crops, groundwater, and livestock, creating major public health and environmental risks. States and municipalities are beginning to limit the amount of waste that can be disposed of via land application, landfills are accepting less of this form of waste, and transportation costs and disposal fees are also increasing as disposal options become more limited. Wastewater treatment facilities are now increasingly looking to innovative waste destruction technologies, such as our AirSCWO system, to fully eliminate and destroy PFAS contaminated biosolids resulting from treatment in wastewater facilities and eliminate the need for further downstream processing.

SCWO

374Water's AirSCWO System Achieves Commercial-Scale Destruction Of PFAS In Biosolids To Non-Detectable Levels

SPSC

SPC Commerce shares are trading lower following the release of its Q2 financial results. Also, Needham cut its price target on the stock from $210 to $160.

<ul>
<li>Frenova and Nephronomics, a renal precision company co-founded by Fresenius Medical Care, initiate collaboration with GENEWIZ by Azenta Life Sciences</li>
<li>Provides vital insights through sophisticated genomic sequencing and analysis of Frenova's My Reason&#xAE; genomic and clinical data registry</li>
<li>Paves way for advances in precision kidney disease care, novel therapies, and diagnostics</li>
</ul>
&nbsp;

Fresenius Medical Care's Third-Party Clinical Research Organization Frenova Collaborates With GENEWIZ To Advance Genomics-Driven, Precision Kidney Disease Care

DDC Enterprise Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DDC#NYSE">DDC</a>) ("DDC" or the "Company"), an Asian consumer-first company at the forefront of corporate bitcoin acquisition and treasury management, today announced a partnership with Matrixport, the world's leading all-in-one hub of crypto financial services, to enhance its institutional-grade custody solutions further.
The Company will integrate Cactus Custody, a regulated digital asset custodian and a subsidiary of Matrixport Group, into its dynamic custodian network, reinforcing its robust asset protection, compliance, and operational flexibility as its Bitcoin holdings continue to grow.
 &nbsp;

DDC Enterprise Partners With Matrixport To Enhance Its Institutional-Grade Custody Solutions Further

Press Releases

Momentus Announces Closing of $5 Million Offering Priced At-The-Market Under NASDAQ Rules

Momentus and Solstar Space Announce Strategic Partnership for On-Demand Communication for Space Systems

Contracts

Small Cap

Velo3D Announces Five-Year Master Service Agreement Valued at $15 Million with Momentus, Inc.

Momentus Signs Long-Term Agreement to Partner with Leading 3D Printing Technology Leader Velo3D

Momentus to Host Portal Space Systems' Inaugural On-orbit Demonstration Mission

Momentus Wins Contract in Highly Competitive U.S. Space Force SpaceWERX Sustained Space Maneuver Challenge

Momentus Awarded NASA Contract for In-Space Power System Demonstration

Momentus Announces $4 Million Offering Priced At-The-Market Under Nasdaq Rules

Momentus and Orbit Fab Partner to Advance Space Servicing with Podracer and RAFTI Demonstration Flight

Momentus Receives Milestone Payments for Successful Execution of DARPA Contract For Assembly of Large Structures in Space

MNTS

VLDX

Air Industries

CPI Aerostructures

New Horizon Aircraft Ltd. - Class A Ordinary Shares

New Horizon Aircraft

Innovative Solutions and Support, Inc. - Common Stock

Innovative Solns

Optex Systems Holdings, Inc. - Common Stock

Optex Systems Hldgs

Sidus Space

SIFCO Industries

Safe Pro Group

Virgin Galactic Holdings, Inc. Common Stock

Virgin Galactic Hldgs

Silynxcom

VirTra

VisionWave Holdings

Screenshot 2025-01-14 at 6.52.33 PM

Emerging Markets

Movers & Shakers

ASTI

Ascent Hit Multiple Milestones In 2024, Helping Power The Future Of Space Energy: Year In Review And Year Ahead

Comments

Momentus

Noticias

Últimas noticias sobre Momentus (NASDAQ:MNTS) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL